Page 10 - Read Online
P. 10

Chu et al.                                                                                                                                                      Meningeal carcinomatosis: a retrospective analysis

           INTRODUCTION                                       17.0 software (SPSS,  IBM,  West Grove, PA,  USA).
                                                              Categorical  data were  presented  as proportions,
           Meningeal  carcinomatosis  (MC) is caused by the   while continuous data were presented as means and
           spread  of cancer cells to the leptomeninges  and   standard deviations of means or interquartile ranges
           by  their  dissemination  within  the  cerebrospinal  fluid   depending on the distribution of the data. Differences
           (CSF).   MC prognosis is usually poor with a short   in proportions were tested by the Chi-square tests and
                 [1]
           survival.  In recent years, several studies focused on   differences in continuous  variables  were tested by
                   [2]
           the early diagnosis of MC. CSF cytology combined   student t-tests. For all statistical tests, P < 0.05 was
           with CSF tumor markers were reported to have great   considered to be significant.
           value for early diagnosis and for addressing the origin
           of meningeal carcinomatos. [3]                     RESULTS

           METHODS                                            The demographic data of MC patients
                                                              Among the 77 patients enrolled to the study, 35
           Patient information                                were males and 42 were females. The median age
           From 2003 to 2013, patients who admitted to        at diagnosis was 55 years old (ranging from 2 to 76
           Department of Neurology at the First Hospital of Jilin   years old).
           University  and  fulfilled  the  diagnostic  criteria  of  MC
           were enrolled.  This retrospective study was approved   Clinical  manifestations  and     physical
                        [4]
           by the ethics  committee  of the First Hospital  of Jilin   examination findings
           University, Changchun, China.                      In this patient cohort, there were 36 (46.2%) cases with
                                                              acute onset, 30 (39%) cases with subacute onset and
           Clinical data                                      11 (14.3%) cases with chronic onset. Most  patients
           A total of 77 patients were enrolled in our study. We   were admitted to hospital  with increased  intracranial
           collected data about the gender, age of onset, type of   pressure symptoms such as headache,  nausea  and
           onset, initial symptoms, clinical manifestations, physical   vomit. Some patients showed cranial  nerve or brain
           examination, time and frequency of lumbar puncture,   parenchyma damage symptoms and severe cases
           CSF pressure, routine biochemical  and cytological   presented  with unconsciousness  or cerebralhernia.
           examination  results, CSF tumor markers, imaging   Physical  examination  revealed  meningeal  irritation,
           examinations [head computed tomography, magnetic   pyramidal signs, cranial nerve paralysis, etc. The main
           resonance imaging (MRI) scan and enhanced scan],   symptoms and signs are shown in Table 1.
           serum tumor markers, primary tumors, the interval
           between primary tumor and central nervous symptoms,   Lumbar puncture and CSF routine test
           treatment methods and the survival time.           Intracranial pressure, CSF  cytology,  tumor
                                                              markers and immunoglobulin
           The above data was provided  by the First  Hospital   The high lumbar puncture intracranial pressure was
           of  Jilin University Clinical  Laboratory and Imaging   observed in 56% (32/57) of cases, and 21.1% of them
           Department.                                        showed over 400 mmH O.  The distribution  of the
                                                                                     2
                                                              intracranial pressure is shown in Figure 1.
           Statistics
           Statistical analysis was performed using SPSS version   In the first CSF cytology examination, 82.2% (60/73)

           Table 1: Symptoms and signs of meningeal carcinomatosis patients
            CNS involvement     Number of    Cranial nerve         Number of   Spinal and PNS      Number of
            symptoms and signs  cases (%)    involvement           cases (%)   involvement         cases (%)
            Headache, nausea and   54 (70.1)  Abducens nerve palsy  10 (13.0)  Bilateral limbs weakness   12 (15.6)
            vomiting                                                           or paresthesia
            Dizziness           21 (27.3)    Oculomotor nerve paralysis  10 (13.0)  Tendon reflexes diminish   11 (14.3)
                                                                               or disappear
            Hyperspasmia        11 (14.3)    Facial paralysis      10 (13.0)   Neck and shoulder pain  5 (6.5)
            Mental disorders    5 (6.5)      Double vision         7 (9.1)     Unsteady gait       3 (3.9)
            Disturbance of      3 (3.9)      Hypoglossal nerve palsy  7 (9.1)  Rectal bladder      1 (1.3)
            consciousness                                                      dysfunction
            Papilledema         4 (5.2)      Decreased vision      4 (5.2)     Saddle area sensory loss  1 (1.3)
            Pyramidal signs     20 (26.0)    Hearing loss          4 (5.2)     Lasegue positive sign  1 (1.3)
            Meningeal irritation  41 (53.2)  Pronunciation or dysphagia  4 (5.2)
           CNS: central nervous system; PNS: peripheral nervous system
             2                                                                    Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ January 20, 2017
   5   6   7   8   9   10   11   12   13   14   15